Akzo Nobel India Inkomsten in het verleden
Verleden criteriumcontroles 6/6
Akzo Nobel India has been growing earnings at an average annual rate of 15.9%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 11.2% per year. Akzo Nobel India's return on equity is 32.4%, and it has net margins of 10.8%.
Belangrijke informatie
15.9%
Groei van de winst
16.9%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 17.7% |
| Inkomstengroei | 11.2% |
| Rendement op eigen vermogen | 32.4% |
| Nettomarge | 10.8% |
| Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Akzo Nobel India geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 39,987 | 4,313 | 4,555 | 0 |
| 31 Mar 24 | 39,616 | 4,266 | 4,501 | 0 |
| 31 Dec 23 | 39,396 | 4,133 | 4,155 | 0 |
| 30 Sep 23 | 38,937 | 3,969 | 4,098 | 0 |
| 30 Jun 23 | 38,636 | 3,681 | 4,025 | 0 |
| 31 Mar 23 | 38,021 | 3,351 | 3,953 | 0 |
| 31 Dec 22 | 37,178 | 3,143 | 3,587 | 0 |
| 30 Sep 22 | 36,453 | 3,008 | 3,462 | 0 |
| 30 Jun 22 | 34,599 | 2,911 | 3,371 | 0 |
| 31 Mar 22 | 31,486 | 2,901 | 3,212 | 0 |
| 31 Dec 21 | 30,629 | 2,897 | 3,119 | 0 |
| 30 Sep 21 | 29,232 | 2,932 | 3,149 | 0 |
| 30 Jun 21 | 27,893 | 3,038 | 3,080 | 0 |
| 31 Mar 21 | 24,214 | 2,076 | 3,080 | 0 |
| 31 Dec 20 | 22,213 | 1,874 | 3,362 | 0 |
| 30 Sep 20 | 21,737 | 1,770 | 3,324 | 0 |
| 30 Jun 20 | 22,006 | 1,600 | 3,377 | 0 |
| 31 Mar 20 | 26,618 | 2,374 | 3,467 | 0 |
| 31 Dec 19 | 27,862 | 2,537 | 3,690 | 0 |
| 30 Sep 19 | 28,424 | 2,371 | 3,688 | 0 |
| 30 Jun 19 | 29,224 | 2,246 | 3,715 | 0 |
| 31 Mar 19 | 29,184 | 2,110 | 3,776 | 0 |
| 31 Mar 18 | 27,193 | 2,052 | 4,103 | 0 |
| 31 Mar 17 | 25,725 | 2,341 | 3,906 | 0 |
| 31 Dec 16 | 28,459 | 2,238 | 3,982 | 0 |
| 30 Sep 16 | 28,306 | 2,261 | 4,001 | 0 |
| 30 Jun 16 | 27,836 | 2,196 | 3,941 | 0 |
| 31 Mar 16 | 26,401 | 2,142 | 3,816 | 0 |
| 31 Dec 15 | 26,328 | 1,942 | 6,505 | 0 |
| 30 Sep 15 | 25,717 | 1,817 | 6,377 | 0 |
| 30 Jun 15 | 25,219 | 1,764 | 6,273 | 0 |
| 31 Mar 15 | 25,151 | 1,863 | 3,394 | 0 |
| 31 Dec 14 | 25,220 | 1,963 | 6,064 | 0 |
| 30 Sep 14 | 24,945 | 1,726 | 6,057 | 0 |
| 30 Jun 14 | 24,843 | 1,706 | 1,960 | 0 |
| 31 Mar 14 | 24,004 | 1,502 | 6,072 | 0 |
| 31 Dec 13 | 23,291 | 1,580 | 5,775 | 114 |
Kwaliteitswinsten: 500710 has high quality earnings.
Groeiende winstmarge: 500710's current net profit margins (10.8%) are higher than last year (9.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 500710's earnings have grown by 15.9% per year over the past 5 years.
Versnelling van de groei: 500710's earnings growth over the past year (17.2%) exceeds its 5-year average (15.9% per year).
Winst versus industrie: 500710 earnings growth over the past year (17.2%) exceeded the Chemicals industry 10.4%.
Rendement op eigen vermogen
Hoge ROE: 500710's Return on Equity (32.4%) is considered high.